Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Creditriskmonitor Com (CRMZ) Cash & Equivalents (2016 - 2025)

Creditriskmonitor Com (CRMZ) has 15 years of Cash & Equivalents data on record, last reported at $6.9 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 12.29% year-over-year to $6.9 million; the TTM value through Sep 2025 reached $6.9 million, down 12.29%, while the annual FY2024 figure was $6.7 million, 39.35% down from the prior year.
  • Cash & Equivalents reached $6.9 million in Q3 2025 per CRMZ's latest filing, up from $5.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $13.6 million in Q3 2022 and bottomed at $5.8 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $10.1 million, with a median of $10.9 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: increased 26.1% in 2021, then plummeted 53.24% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $12.4 million in 2021, then fell by 20.31% to $9.9 million in 2022, then rose by 11.54% to $11.0 million in 2023, then plummeted by 39.35% to $6.7 million in 2024, then rose by 3.65% to $6.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $6.9 million in Q3 2025, $5.8 million in Q2 2025, and $5.8 million in Q1 2025.